Conclusion
To conclude, severe hypercholesterolemia mediated by Lp-X in post-HSCT
patients with liver GVHD is a recognized yet overlooked phenomenon.
Transplant physicians and endocrinologists should have increased
awareness of this association and avoid unnecessary and ineffective
usage of statins.